Recently, the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver "APASL 2024 Kyoto-APASL: The Center of Hepatology" was officially held in Kyoto, Japan. Over 6,000 participants from more than 80 countries attended the annual meeting. Multiple prestigious scholars in the field of liver diseases were invited to share the latest research and insights in the academic community. At this annual meeting, multiple clinical guidelines, major clinical research results, prevention and treatment strategies and the latest understanding of the research status and trends in the field of hepatology were released.
At APASL Annual Meeting, Hu Liangshuo, Deputy Chief Physician in liver transplantation sub-discipline of Department of Hepatobiliary Surgery in the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU), and PhD Mu Fan were invited to deliver presentations on the team’s research achievements in the fields of liver transplantation and malignant liver tumors, respectively.
Deputy Chief Physician Hu Liangshuo gave an oral presentation regarding the results of national multi-center clinical research on the application of elderly donor liver in liver transplantation for liver cancer and multi-center retrospective cohort study on preventing SARS-CoV-2 infection in recipients undergoing liver transplantation, and introduced the medical engineering results on the evaluation of donor liver quality by hyperspectral imaging in FAH. Besides, he conducted heated discussion with scholars from Mayo Clinic, The University of Tokyo, The University of Sydney and other centers. Based on the above researches, the team published a series of high-level original research results in International Journal of Surgery (IF 15.3) in 2023 and QJM (IF 13.3) in 2024, etc. PhD Mu Fan gave an oral presentation on the team’s basic research progress in the effect of FLNA-related pathways on lymphatic metastasis of intrahepatic cholangiocarcinoma, and discussed with Professor Yamada from Osaka University regarding the establishment of bile duct-derived intrahepatic cholangiocarcinoma models.
The liver transplantation sub-discipline of Department of Hepatobiliary Surgery in FAH undertakes the most advanced liver transplantation work in northwest China. Since 2000, it has completed more than 1400 cases of liver transplantation. The quantity and efficacy of liver transplantation rank among top 10 in China, ranking 1st in the western region and leading at the national level in China.
